Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Travere Therapeutics Inc.

Travere Therapeutics Inc. (TVTX)

Market is closed
News
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q2 2023 Earnings Call Transcript

Travere Therapeutics, Inc. (NASDAQ:TVTX) Q2 2023 Earnings Call Transcript

Operator: Good day, and welcome to the Travere Therapeutics Second Quarter 2023 Financial Results and Corporate Update Conference Call. Today's conference call is being recorded.

Keep Reading →

August 8th, 2023 - News Transcripts

Travere Therapeutics, Inc. (NASDAQ:TVTX) Q1 2023 Earnings Call Transcript

Operator: Good day, and welcome to the Travere Therapeutics First Quarter 2023 Financial Results and Corporate Update Conference Call. Today's conference is being recorded.

Keep Reading →

May 9th, 2023 - News Transcripts

Travere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2022 Earnings Call Transcript

Operator: Good day, and welcome to the Travere Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update. Today's conference call is being recorded.

Keep Reading →

February 28th, 2023 - News Transcripts

10 Best Pharmaceutical Stocks to Buy According to Steven Boyd's Armistice Capital

10 Best Pharmaceutical Stocks to Buy According to Steven Boyd's Armistice Capital

In this article, we will take a look at some of the notable pharma stocks to buy according to Steven Boyd's Armistice Capital.

Keep Reading →

October 7th, 2022 - Hedge Funds News

10 Small-Cap Value Stocks Hedge Funds Love

10 Small-Cap Value Stocks Hedge Funds Love

After more than a decade of being routinely crushed by growth stocks, value stocks are finally getting some love in 2022, as rampant inflation and fears of a recession have caused investors to unload ...

Keep Reading →

August 11th, 2022 - Hedge Funds News

Travere Therapeutics, Inc. (TVTX) Fell Out Of Favor With Hedge Funds?

Travere Therapeutics, Inc. (TVTX) Fell Out Of Favor With Hedge Funds?

We at Insider Monkey have gone over 867 13F filings that hedge funds and prominent investors are required to file by the SEC.

Keep Reading →

December 12th, 2021 - Hedge Funds News

Do Hedge Funds Love Travere Therapeutics, Inc. (TVTX)?

Do Hedge Funds Love Travere Therapeutics, Inc. (TVTX)?

In this article we will check out the progression of hedge fund sentiment towards Travere Therapeutics, Inc. (NASDAQ:TVTX) and determine whether it is a good investment right now.

Keep Reading →

October 25th, 2021 - Hedge Funds News

5 Best Biotech Stocks to Buy According to Joseph Edelman’s Perceptive Advisors

5 Best Biotech Stocks to Buy According to Joseph Edelman’s Perceptive Advisors

In this article, we will discuss the 5 best biotech stocks to buy according to Joseph Edelman's Perceptive Advisors based on Q2 holdings of the fund.

Keep Reading →

October 15th, 2021 - Hedge Funds News

Where Do Hedge Funds Stand On Travere Therapeutics, Inc. (TVTX)?

Where Do Hedge Funds Stand On Travere Therapeutics, Inc. (TVTX)?

In this article we will analyze whether Travere Therapeutics, Inc.

Keep Reading →

July 13th, 2021 - Hedge Funds News

5 Best Biotech Stocks to Invest In

5 Best Biotech Stocks to Invest In

A clinical-stage biopharmaceutical company Global Blood Therapeutics, Inc. (NASDAQ: GBT) is the long-running investment of a billionaire hedge fund manager.

Keep Reading →

December 19th, 2020 - News

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)